1. Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions

   • Matthew P. Rutman
   • John R. Horn
   • Richard G. Stefanacci

   Review Article Open access 12 March 2021 Pages: 293 - 302

   

2. Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects

   • Carla Rognoni
   • Arianna Bertolani
   • Claudio Jommi

   Systematic Review Open access 09 March 2021 Pages: 303 - 319

   

3. Overall Efficacy and Safety of Safinamide in Parkinson’s Disease: A Systematic Review and a Meta-analysis

   • Riccardo Giossi
   • Federica Carrara
   • Francesco Scaglione

   Systematic Review Open access 05 March 2021 Pages: 321 - 339

   

4. Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis

   • Hsin-Yu Chen
   • Shih-Hsiang Ou
   • Yi-Chia Su

   Systematic Review 11 March 2021 Pages: 341 - 351

   

5. Safety and Efficacy of Rivaroxaban and Apixaban in Patients with Increased Body Mass: a Systematic Review

   • Margaret M. Buck
   • Alexa M. Haddon
   • Courtney A. Montepara

   Systematic Review 07 March 2021 Pages: 353 - 369

   

6. Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece

   • George Gourzoulidis
   • Charalampos Tzanetakos
   • Georgia Kourlaba

   Original Research Article 09 March 2021 Pages: 371 - 380

   

7. Cost-effectiveness Analysis of Atezolizumab Plus Nab-Paclitaxel for Advanced PD-L1 Positive Triple-Negative Breast Cancer in Japan

   • Yugo Chisaki
   • Yoshiki Kuwada
   • Yoshitaka Yano

   Original Research Article 05 March 2021 Pages: 381 - 389

   

8. Pharmacokinetics and Pharmacodynamics of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects After Single Subcutaneous Administration

   • Narihisa Miyachi
   • Oleh Zagrijtschuk
   • Albert Qin

   Original Research Article 16 March 2021 Pages: 391 - 404

   

9. Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use

   • Sheridan M. Hoy

   Adis Drug Q&A Open access 16 March 2021 Pages: 405 - 412

10. Correction to: The CITIMERIVA Study: CITIcoline plus MEmantine plus RIVAstigmine in Older Patients Affected with Alzheimer’s Disease

    • Alberto Castagna
    • Ciro Manzo
    • Giovanni Ruotolo

    Correction 27 February 2021 Pages: 413 - 413